Unknown

Dataset Information

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.


ABSTRACT:

Purpose

Picoplatin is a new generation platinum designed to overcome platinum resistance. The goal of this study was to assess picoplatin anti-tumor activity and measure various cellular parameters in small-cell lung cancer (SCLC) cells resistant to cell killing by cisplatin and carboplatin.

Methods

We developed several platinum-resistant SCLC cell lines to evaluate picoplatin activity and drug resistance mechanisms in vitro. Drug cytotoxicity was measured by MTS assay. Total cellular platinum accumulation was measured by inductively coupled plasma mass spectrometry (ICP-MS). Whole genome gene expression profiling was carried out by microarray analysis.

Results

Picoplatin retained significant cytotoxic activity in platinum-resistant SCLC lines compared to cisplatin an

SUBMITTER: Tang CH 

PROVIDER: S-EPMC3102205 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature